COVID Cohort

(total patients N = 48)

Group A:

pre-COVID-19 testing(N = 18)

Group B:

symptomatic COVID-19 (N = 19)

Group C:

asymptomatic COVID-19 (N = 9)

Group D:

pre-symptomatic COVID-19 (N = 2)

mean age

(range)- y

85 ± 5

(77-100)

85 ± 8

(64-96)

86 ± 5

(range 80-97)

88

(range 84-92)

Sex- (N)

·         Male

·         Female

5

13

13

6

3

8

2

0

Mean duration of FU/survival after symptom/sign onset- N. days

7

47

asymptomatic

(9 patients)

33

Mean duration of FU/survival after rapid deterioration- N. days

2

4.5 ± 3.5

(range 1-8 die)

FU on-going

2.5 ± 0.5

Respiratory symptoms- (N)

·         Cough

·         Sore throat

0

0

5

2

0

0

Other symptoms- (N)

·         Diarrhea

·         Malaise

1

1

1

1

0

1

Signs- (N)

·         >38°C

·         <38°C

·         Oxygen saturation < 90%

5

10

2

3

5

2

0

1

2

Terminal palliative approach- (N)

·         Palliative sedation

·         Terminal sedation

10

1

2

0

0

1

1

Chronic underlying conditions N. (%)

·         Age > 90 years

2 (11)

3 (16)

5 (55)

1 (50)

·         Cancer

1 (5)

0

0

0

·         Encephalopaties

13 (72)

10 (52)

6 (66)

2 (100)

·         Pulmonary disease

1 (5)

1 (5)

2 (22)

0

·         Ischemic heart disease

3 (16)

7 (36)

1 (11)

0

·         Hypertension

3 (16)

7 (36)

4 (44)

2 (100)

·         Diabetes mellitus

3 (16)

3 (15)

0

0

·         Obesity

3 (16)

0

2 (22)

0

·         Pulmonary hypertension

(history of PE)

0

0

1 (11)

0